Efficacy of Intravenous Tranexamic Acid in Reducing Blood Loss after Elective Cesarean Section: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

ABSTRACT

We sought to determine the efficacy and safety of tranexamic acid (TA) in reducing blood loss during elective cesarean section (CS). We performed a randomized, double-blind, placebo-controlled study of 660 women who underwent elective CS. The patients were randomly selected to receive an intravenous infusion of either TA (1 g/10 mL in 20 mL of 5% glucose; n = 330) or 30 mL 5% glucose prior to surgery. The primary outcome was the estimated blood loss following CS. No demographic difference was observed between groups. The mean estimated blood loss was significantly lower in women treated with TA compared with women in the placebo group (499.9 ± 206.4 mL versus 600.7 ± 215.7 mL, respectively; p < 0.001), and the proportion of women in the TA group who had an estimated blood loss >1000 mL was significantly lower than in the placebo group (7 [2.1%] versus 19 [5.8%], respectively; relative risk [RR] 2.7; 95% confidence interval [CI] 1.1 to 6.3; p < 0.03). Furthermore, more women in the placebo group than in the TA group required additional uterotonic agents (48 [14.5%] versus 28 [8.5%], respectively; RR 1.7; 95% CI 1.1 to 2.6; p = 0.02). Maternal and neonatal outcomes did not differ significantly. TA significantly reduced bleeding during CS, the percentage of patients with blood loss >1000 mL, and the need for additional uterotonic agents. Furthermore, the incidence of thromboembolic events did not increase. Our results suggest that TA can be used safely and effectively to reduce CS bleeding.

KEYWORDS

Tranexamic acid - cesarean section - blood loss - randomized control trial

REFERENCES

• 1 Magann E F, Evans S, Hutchinson M, Collins R, Lanneau G, Morrison J C. Postpartum hemorrhage after cesarean delivery: an analysis of risk factors.  South Med J. 2005;  98 681-685
• 2 Güngördük K, Asicioglu O, Celikkol O, Olgac Y, Ark C. Use of additional oxytocin to reduce blood loss at elective caesarean section: a randomised control trial.  Aust N Z J Obstet Gynaecol. 2010;  50 36-39
• 3 Ahmed B, Abu Nahia F, Abushama M. Routine cervical dilatation during elective cesarean section and its influence on maternal morbidity: a randomized controlled study.  J Perinat Med. 2005;  33 510-513
• 4 Caesarean Section .Clinical Guideline. National Collaborating Centre for Women's and Children's Health. London: RCOG Press; 2004
• 5 Bolton T J, Randall K, Yentis S M. Effect of the confidential enquiries into maternal deaths on the use of syntocinon at caesarean section in the UK.  Anaesthesia. 2003;  58 277-279
• 6 Prentice A. Fortnightly review. Medical management of menorrhagia.  BMJ. 1999;  319 1343-1345
• 7 Gleeson N C, Buggy F, Sheppard B L, Bonnar J. The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding.  Acta Obstet Gynecol Scand. 1994;  73 274-277
• 8 Dunn C J, Goa K L. Tranexamic acid: a review of its use in surgery and other indications.  Drugs. 1999;  57 1005-1032
• 9 Novikova N, Hofmeyr G J. Tranexamic acid for preventing postpartum haemorrhage.  Cochrane Database Syst Rev. 2010;  7 CD007872
• 10 As A K, Hagen P, Webb J B. Tranexamic acid in the management of postpartum haemorrhage.  Br J Obstet Gynaecol. 1996;  103 1250-1251
• 11 Gai M Y, Wu L F, Su Q F, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.  Eur J Obstet Gynecol Reprod Biol. 2004;  112 154-157
• 12 Gohel M, Patel P, Gupta A, Desai P. Efficacy of tranexamic acid in decreasing blood loss during and after caesarean section: a randomized case controlled prospective study.  J Obstet Gynaecol India. 2007;  57 228-230
• 13 Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T, Tafti A D. Efficacy of tranexamic acid in reducing blood loss after cesarean section.  J Matern Fetal Neonatal Med. 2009;  22 72-75
• 14 Shook P R, Schultz J R, Reynolds J D, Spahn T E, DeBalli P. Estimating blood loss for cesarean section: how accurate are we?.  Anesthesiology. 2003;  98 (Suppl) A1
• 15 Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H. Anti-fibrinolytic agents in post partum haemorrhage: a systematic review.  BMC Pregnancy Childbirth. 2009;  9 29
• 16 Stafford I, Dildy G A, Clark S L, Belfort M A. Visually estimated and calculated blood loss in vaginal and cesarean delivery.  Am J Obstet Gynecol. 2008;  199 519.e1-519.e7
• 17 Wellington K, Wagstaff A J. Tranexamic acid: a review of its use in the management of menorrhagia.  Drugs. 2003;  63 1417-1433
• 18 Fiechtner B K, Nuttall G A, Johnson M E et al.. Plasma tranexamic acid concentrations during cardiopulmonary bypass.  Anesth Analg. 2001;  92 1131-1136
• 19 Henry D A, Moxey A J, Carless P A et al.. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.  Cochrane Database Syst Rev. 2001;  (1) CD001886
• 20 Mousa H A, Alfirevic Z. Major postpartum hemorrhage: survey of maternity units in the United Kingdom.  Acta Obstet Gynecol Scand. 2002;  81 727-730